Anti-VEGF in a Marathon Runner’s Retinopathy Case

<div>Fundus microperimetry (Macular Integrity Assessment, MAIA, CenterVue, Padova, Italy) of the right eye: initial exam, at presentation, showing decreased retinal sensitivity (a). Following ranibizumab treatment, marked improvement in retinal sensitivity (b).</div>

Case Reports in Ophthalmological Medicine

fig2

Figure 2

Figure 2: Anti-VEGF in a Marathon Runner’s Retinopathy Case 